http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 27 Aug 2026 16:01:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Optimi+Health+Corp.++++++++++++++++++/26989710.html si-local-file:///var/storage/secattach/20260827/26989710.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Optimi+Health+Corp.++++++++++++++++++/26989710.html Thu, 27 Aug 2026 16:01:00 -0400 O.53098441 OPTH http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Optimi+Health+Corp.++++++++++++++++++/26989710.html si-local-file:///var/storage/secattach/20260827/26989710.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Optimi+Health+Corp.++++++++++++++++++/26989710.html Thu, 27 Aug 2026 16:01:00 -0400 O.53098441 OPTH http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+26/26984064.html si-local-file:///var/storage/secattach/20260827/26984064.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+26/26984064.html Thu, 27 Aug 2026 06:05:00 -0400 O.53098441 OPTH http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+26/26984064.html si-local-file:///var/storage/secattach/20260827/26984064.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+26/26984064.html Thu, 27 Aug 2026 06:05:00 -0400 O.53098441 OPTH http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Optimi+Health+Corp.++++++++++++++++++/26976871.html si-local-file:///var/storage/secattach/20260826/26976871.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Optimi+Health+Corp.++++++++++++++++++/26976871.html Wed, 26 Aug 2026 06:05:00 -0400 O.53098441 OPTH http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Optimi+Health+Corp.++++++++++++++++++/26976871.html si-local-file:///var/storage/secattach/20260826/26976871.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Optimi+Health+Corp.++++++++++++++++++/26976871.html Wed, 26 Aug 2026 06:05:00 -0400 O.53098441 OPTH http://www.streetinsider.com/Equity+Offerings/Optimi+Health+%28OPTH%29+files+for+up+to+21.94M+share+offering+by+selling+stockholders/26934181.html <p>Optimi Health (NASDAQ: OPTH) files for up to 21,943,260 share offering by selling stockholders.</p> http://www.streetinsider.com/Equity+Offerings/Optimi+Health+%28OPTH%29+files+for+up+to+21.94M+share+offering+by+selling+stockholders/26934181.html Mon, 17 Aug 2026 06:05:14 -0400 OPTH http://www.streetinsider.com/Corporate+News/Optimi+Health+%28OPTH%29+files+for+up+to+21.94M+share+offering+by+selling+stockholders/26934181.html <p>Optimi Health (NASDAQ: OPTH) files for up to 21,943,260 share offering by selling stockholders.</p> http://www.streetinsider.com/Corporate+News/Optimi+Health+%28OPTH%29+files+for+up+to+21.94M+share+offering+by+selling+stockholders/26934181.html Mon, 17 Aug 2026 06:05:14 -0400 OPTH http://www.streetinsider.com/SEC+Filings/Form++F-1++++++++Optimi+Health+Corp.++++++++++++++++++/26934129.html si-local-file:///var/storage/secattach/20260817/26934129.html http://www.streetinsider.com/SEC+Filings/Form++F-1++++++++Optimi+Health+Corp.++++++++++++++++++/26934129.html Mon, 17 Aug 2026 06:01:00 -0400 O.53098441 OPTH http://www.streetinsider.com/SEC+Filings/Form++F-1++++++++Optimi+Health+Corp.++++++++++++++++++/26934129.html si-local-file:///var/storage/secattach/20260817/26934129.html http://www.streetinsider.com/SEC+Filings/Form++F-1++++++++Optimi+Health+Corp.++++++++++++++++++/26934129.html Mon, 17 Aug 2026 06:01:00 -0400 O.53098441 OPTH http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+14/26932790.html si-local-file:///var/storage/secattach/20260814/26932790.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+14/26932790.html Fri, 14 Aug 2026 17:19:00 -0400 O.53098441 OPTH http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+14/26932790.html si-local-file:///var/storage/secattach/20260814/26932790.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+14/26932790.html Fri, 14 Aug 2026 17:19:00 -0400 O.53098441 OPTH http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jun+30/26932400.html si-local-file:///var/storage/secattach/20260814/26932400.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jun+30/26932400.html Fri, 14 Aug 2026 17:00:00 -0400 O.53098441 OPTH http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jun+30/26932400.html si-local-file:///var/storage/secattach/20260814/26932400.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jun+30/26932400.html Fri, 14 Aug 2026 17:00:00 -0400 O.53098441 OPTH http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html <p align="justify">VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “<strong>Company</strong>” or “<strong>Optimi</strong>”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “<strong>Purchase Agreement</strong>”) with Seven Knots, LLC (“<strong>Seven Knots</strong>”), establishing an equity line of credit (the “<strong>ELOC</strong>”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.</p> <p align="justify">Sales http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html Fri, 14 Aug 2026 16:55:00 -0400 8BN0 A.41031841 O.00009986 O.53098441 OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html <p align="justify">VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “<strong>Company</strong>” or “<strong>Optimi</strong>”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “<strong>Purchase Agreement</strong>”) with Seven Knots, LLC (“<strong>Seven Knots</strong>”), establishing an equity line of credit (the “<strong>ELOC</strong>”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.</p> <p align="justify">Sales http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html Fri, 14 Aug 2026 16:55:00 -0400 8BN0 A.41031841 O.00009986 O.53098441 OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html <p align="justify">VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “<strong>Company</strong>” or “<strong>Optimi</strong>”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “<strong>Purchase Agreement</strong>”) with Seven Knots, LLC (“<strong>Seven Knots</strong>”), establishing an equity line of credit (the “<strong>ELOC</strong>”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.</p> <p align="justify">Sales http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html Fri, 14 Aug 2026 16:55:00 -0400 8BN0 A.41031841 O.00009986 O.53098441 OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html <p align="justify">VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “<strong>Company</strong>” or “<strong>Optimi</strong>”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “<strong>Purchase Agreement</strong>”) with Seven Knots, LLC (“<strong>Seven Knots</strong>”), establishing an equity line of credit (the “<strong>ELOC</strong>”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.</p> <p align="justify">Sales http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html Fri, 14 Aug 2026 16:55:00 -0400 8BN0 A.41031841 O.00009986 O.53098441 OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html <p align="justify">VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “<strong>Company</strong>” or “<strong>Optimi</strong>”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “<strong>Purchase Agreement</strong>”) with Seven Knots, LLC (“<strong>Seven Knots</strong>”), establishing an equity line of credit (the “<strong>ELOC</strong>”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.</p> <p align="justify">Sales http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html Fri, 14 Aug 2026 16:55:00 -0400 8BN0 A.41031841 O.00009986 O.53098441 OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html <p align="justify">VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “<strong>Company</strong>” or “<strong>Optimi</strong>”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “<strong>Purchase Agreement</strong>”) with Seven Knots, LLC (“<strong>Seven Knots</strong>”), establishing an equity line of credit (the “<strong>ELOC</strong>”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.</p> <p align="justify">Sales http://www.streetinsider.com/Press+Releases/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html Fri, 14 Aug 2026 16:55:00 -0400 8BN0 A.41031841 O.00009986 O.53098441 OPTH OPTI http://www.streetinsider.com/Globe+Newswire/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html <p align="justify">VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “<strong>Company</strong>” or “<strong>Optimi</strong>”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “<strong>Purchase Agreement</strong>”) with Seven Knots, LLC (“<strong>Seven Knots</strong>”), establishing an equity line of credit (the “<strong>ELOC</strong>”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.</p> <p align="justify">Sales http://www.streetinsider.com/Globe+Newswire/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html Fri, 14 Aug 2026 16:55:00 -0400 8BN0 A.41031841 O.00009986 O.53098441 OPTH OPTI http://www.streetinsider.com/Globe+Newswire/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html <p align="justify">VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “<strong>Company</strong>” or “<strong>Optimi</strong>”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “<strong>Purchase Agreement</strong>”) with Seven Knots, LLC (“<strong>Seven Knots</strong>”), establishing an equity line of credit (the “<strong>ELOC</strong>”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.</p> <p align="justify">Sales http://www.streetinsider.com/Globe+Newswire/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html Fri, 14 Aug 2026 16:55:00 -0400 8BN0 A.41031841 O.00009986 O.53098441 OPTH OPTI http://www.streetinsider.com/Globe+Newswire/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html <p align="justify">VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “<strong>Company</strong>” or “<strong>Optimi</strong>”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “<strong>Purchase Agreement</strong>”) with Seven Knots, LLC (“<strong>Seven Knots</strong>”), establishing an equity line of credit (the “<strong>ELOC</strong>”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.</p> <p align="justify">Sales http://www.streetinsider.com/Globe+Newswire/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html Fri, 14 Aug 2026 16:55:00 -0400 8BN0 A.41031841 O.00009986 O.53098441 OPTH OPTI http://www.streetinsider.com/Globe+Newswire/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html <p align="justify">VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “<strong>Company</strong>” or “<strong>Optimi</strong>”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “<strong>Purchase Agreement</strong>”) with Seven Knots, LLC (“<strong>Seven Knots</strong>”), establishing an equity line of credit (the “<strong>ELOC</strong>”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.</p> <p align="justify">Sales http://www.streetinsider.com/Globe+Newswire/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html Fri, 14 Aug 2026 16:55:00 -0400 8BN0 A.41031841 O.00009986 O.53098441 OPTH OPTI http://www.streetinsider.com/Globe+Newswire/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html <p align="justify">VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “<strong>Company</strong>” or “<strong>Optimi</strong>”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “<strong>Purchase Agreement</strong>”) with Seven Knots, LLC (“<strong>Seven Knots</strong>”), establishing an equity line of credit (the “<strong>ELOC</strong>”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.</p> <p align="justify">Sales http://www.streetinsider.com/Globe+Newswire/Optimi+Health+Establishes+Discretionary+Equity+Facility/26932276.html Fri, 14 Aug 2026 16:55:00 -0400 8BN0 A.41031841 O.00009986 O.53098441 OPTH OPTI